1. Home
  2. BIO vs CTRE Comparison

BIO vs CTRE Comparison

Compare BIO & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

SELL

Current Price

$364.61

Market Cap

10.1B

Sector

Industrials

ML Signal

SELL

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

SELL

Current Price

$36.60

Market Cap

9.9B

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
BIO
CTRE
Founded
1952
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.9B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
BIO
CTRE
Price
$364.61
$36.60
Analyst Decision
Hold
Strong Buy
Analyst Count
3
13
Target Price
★ $328.33
$44.62
AVG Volume (30 Days)
256.4K
★ 2.1M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
★ 4.33%
EPS Growth
★ 142.61
96.25
EPS
N/A
★ 0.74
Revenue
★ $2,583,200,000.00
$476,393,000.00
Revenue This Year
N/A
$36.44
Revenue Next Year
$2.13
$22.85
P/E Ratio
★ N/A
$48.74
Revenue Growth
0.65
★ 60.79
52 Week Low
$236.73
$32.79
52 Week High
$396.23
$43.62

Technical Indicators

Market Signals
Indicator
BIO
CTRE
Relative Strength Index (RSI) 45.64 41.64
Support Level $358.85 $35.85
Resistance Level $392.81 $40.12
Average True Range (ATR) 12.52 0.57
MACD -2.22 0.02
Stochastic Oscillator 30.27 52.69

Price Performance

Historical Comparison
BIO
CTRE

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

Share on Social Networks: